Heparin in the treatment of cerebral venous thrombosis

Journal of the Pakistan Medical Association

Volumn 56, Issue 11, 2006, Pages 541-543

  Shafqat, Saad ^a   Kamal, Ayeesha K ^a   Wasay, Mohammad ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ARGATROBAN; HEPARIN; LEPRIUDIN; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG; WARFARIN; XIMELAGATRAN; ANTICOAGULANT AGENT;

BLEEDING; BLOOD CLOT LYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HUMAN; INTRACRANIAL PRESSURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PHLEBOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; THROMBOCYTOPENIA; TREATMENT DURATION; BRAIN VEIN; CEREBRAL SINUS THROMBOSIS; FIBRINOLYTIC THERAPY; PATHOLOGY; RISK FACTOR; VEIN THROMBOSIS;

ANTICOAGULANTS; CEREBRAL VEINS; HEPARIN; HUMANS; INTRACRANIAL THROMBOSIS; RISK FACTORS; SINUS THROMBOSIS, INTRACRANIAL; THROMBOLYTIC THERAPY; VENOUS THROMBOSIS;

EID: 33847364912     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Ribes MF. Des recherches faites sur la phlebite. Revue Medicale Francaise et Etrangere et Journal de Clinique de l'Hotel-Dieu et de la Charite de Paris 1825; 3:5
2. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-70.
3. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005; 352:1791-8.
4. Bousser MG, Barnett HJM. Cerebral venous thrombosis. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds.) Stroke: Pathophysiology, Diagnosis and Management, Churchill Livingstone (New York); 1998:623-7.
5. Lafitte F, Boukobza M, Guichard JP, Hoeffel C, Reizine D, Ille O, Woimant F, Merland JJ. MRI and MRA for diagnosis and follow-up of cerebral venous thrombosis (CVT). Clin Radoil 1997; 52:672-9.
6. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119(1 Suppl):64S-94S.
7. Weitz JI. Low-molecular-weight heparins. N Engl J Med 1997; 337:688-98.
8. deBruijn SF, Stam J. Randomized placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30:484-8.
9. Bousser MG, Chiras J, Bories J, Castaigne P. Cerebral venous thrombosis: a review of 38 cases. Stroke 1985; 16:199-213.
10. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338:597-600.
11. Halpern JP, Morris JGL, Driscoll GL. Anticoagulants and cerebral venous thrombosis. Aust NZ J Med 1984; 14:643-8.
12. Nagaraja D, Rao BSS, Taly AB, Subhash MN. Randomizd controlled trial of heparin in puerperal cerebral venous/sinus thrombosis. Nimhans J 1995;13:111-5.
13. Stam J, deBruin SF, deVeber G. Anticoagulation for cerebal sinus thrombosis. Stroke 2003; 34:1054-5.
14. Franvis CW. Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation. Curr Pharm Des 2005; 11:3931-41.